Persephone (Drug Discovery) Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $6.3M

  • Investors
  • 28

Persephone (Drug Discovery) General Information

Description

Developer of equitable precision medicines designed to focus on microbial therapeutics for immuno-oncology applications. The company's medicines use artificial intelligence and omics techniques on multiple cancer patient gut microbiomes and blood samples to identify microbes needed for normal immune function for population-scale patient data analytics, enabling lab researchers to design microbial drugs that prevent and fight cancer.

Contact Information

Formerly Known As
Persephone Biome
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3210 Merryfield Row
  • Suite 5800C
  • San Diego, CA 92121
  • United States
+1 (714)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 3210 Merryfield Row
  • Suite 5800C
  • San Diego, CA 92121
  • United States
+1 (714)

Persephone (Drug Discovery) Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Persephone (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 09-Jan-2024 $6.3M Completed Generating Revenue
5. Secondary Transaction - Private 01-Oct-2022 Completed Generating Revenue
4. Seed Round 13-Jul-2022 Completed Generating Revenue
3. Accelerator/Incubator 08-Jan-2018 Completed Generating Revenue
2. Angel (individual) 17-Jul-2017 $200K $200K Completed Startup
1. Accelerator/Incubator 17-Jul-2017 Completed Startup
To view Persephone (Drug Discovery)’s complete valuation and funding history, request access »

Persephone (Drug Discovery) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed-3
Seed-2 1,044,676 $0.000100 $0.02 $0.22 $0.22 1x $0.22 2.46%
To view Persephone (Drug Discovery)’s complete cap table history, request access »

Persephone (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of equitable precision medicines designed to focus on microbial therapeutics for immuno-oncology applications.
Drug Discovery
San Diego, CA
21 As of 2024

Paris, France
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Persephone (Drug Discovery) Competitors (3)

One of Persephone (Drug Discovery)’s 3 competitors is Eligo Bioscience, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eligo Bioscience Venture Capital-Backed Paris, France
Second Genome Formerly VC-backed Brisbane, CA
MatriSys Bioscience Venture Capital-Backed La Jolla, CA
You’re viewing 3 of 3 competitors. Get the full list »

Persephone (Drug Discovery) Patents

Persephone (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230158088-A1 Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same Pending 26-Mar-2020
US-20220378855-A1 Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same Pending 20-Dec-2019
EP-4076482-A1 Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same Pending 20-Dec-2019
EP-4076482-A4 Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same Pending 20-Dec-2019
US-D957246-S1 Collection container Active 28-Feb-2019
To view Persephone (Drug Discovery)’s complete patent history, request access »

Persephone (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Persephone (Drug Discovery) Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mesa Verde Venture Partners Venture Capital Minority
Ocampo Capital Venture Capital Minority
Rhea Capital Management (Los Angeles) Venture Capital Minority
Ayokunle Omojola Angel (individual) Minority
Biobrit Venture Capital Minority
You’re viewing 5 of 28 investors. Get the full list »

Persephone (Drug Discovery) FAQs

  • When was Persephone (Drug Discovery) founded?

    Persephone (Drug Discovery) was founded in 2017.

  • Where is Persephone (Drug Discovery) headquartered?

    Persephone (Drug Discovery) is headquartered in San Diego, CA.

  • What is the size of Persephone (Drug Discovery)?

    Persephone (Drug Discovery) has 21 total employees.

  • What industry is Persephone (Drug Discovery) in?

    Persephone (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Persephone (Drug Discovery) a private or public company?

    Persephone (Drug Discovery) is a Private company.

  • What is the current valuation of Persephone (Drug Discovery)?

    The current valuation of Persephone (Drug Discovery) is .

  • What is Persephone (Drug Discovery)’s current revenue?

    The current revenue for Persephone (Drug Discovery) is .

  • How much funding has Persephone (Drug Discovery) raised over time?

    Persephone (Drug Discovery) has raised $21.6M.

  • Who are Persephone (Drug Discovery)’s investors?

    Mesa Verde Venture Partners, Ocampo Capital, Rhea Capital Management (Los Angeles), Ayokunle Omojola, and Biobrit are 5 of 28 investors who have invested in Persephone (Drug Discovery).

  • Who are Persephone (Drug Discovery)’s competitors?

    Eligo Bioscience, Second Genome, and MatriSys Bioscience are competitors of Persephone (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »